Alkem Laboratories Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Alkem Laboratories announced the launch of Renocia cyclical therapy kit, a scientifically-designed weekly nutritional supplementation regimen to support hair growth, strengthen hair follicles and manage hair loss. The supplements in the kit are made using only vegetarian-sourced ingredients.

Renocia cyclical therapy kit contains a set of nutritional supplements, including vitamins, minerals, and amino acids, each to be taken on designated days of the week. This structured weekly protocol enables better nutrient absorption and utilisation.

Alkem has a growing portfolio of products in the dermatology segment, which includes skin and hair care. Under the Renocia brand, the company offers several products for hair care such as hair revitalizing shampoo, conditioner and serum, as well as oral supplements.

Powered by Capital Market - Live News

Alkem Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at Rs 5418, down 1.58% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.17% on the day, quoting at 25897.6. The Sensex is at 84563.41, down 0.16%.Alkem Laboratories Ltd has eased around 3.41% in last one month.Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has eased around 2.07% in last one month and is currently quoting at 22578.3, down 0.72% on the day. The volume in the stock stood at 38116 shares today, compared to the daily average of 62815 shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 5422.5, down 1.44% on the day. Alkem Laboratories Ltd tumbled 3.83% in last one year as compared to a 9.53% rally in NIFTY and a 4.26% fall in the Nifty Pharma index.

The PE of the stock is 29.41 based on TTM earnings ending September 25.

Powered by Capital Market - Live News

Alkem Laboratories announced that Rakesh Tripathi, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 08 December 2025.

Powered by Capital Market - Live News

Alkem Laboratories announced that Prakash Ramnani has been appointed at senior management position in the Company effective from 05 December 2025.

Powered by Capital Market - Live News